Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eben Tessari currently holds 23,130 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eben Tessari has been a net seller of KNSA stock. They have purchased $0 and sold $14.4M worth of shares.
Eben Tessari's most recent insider trade was on Apr 7, 2026, when they sold 2,726 shares at $0.00 per share.
Eben Tessari serves as Executive at Kiniksa Pharmaceuticals, Ltd. (KNSA). They have executed 94 insider transactions totaling $14.4M over their tenure at the company.
Eben Tessari holds the position of Executive at Kiniksa Pharmaceuticals, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Eben Tessari has shown a selling trading pattern, with $0 in total purchases and $14.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eben Tessari was on Aug 5, 2025, when they sold $4.6M worth of KNSA shares. This transaction involved 138,064 shares at $33.20 per share.
Eben Tessari currently owns 23,130 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eben Tessari's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eben Tessari has 94 Form 4 filings on record as an insider at Kiniksa Pharmaceuticals, Ltd..
Set alerts for Eben Tessari and 40,000+ other insiders.